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Article: Bravo 48-hour wireless pH monitoring in patients with non-cardiac chest pain. Objective gastroesophageal 
reflux disease parameters predict the responses to proton pump inhibitors
Karamanolis G, Triantafyllou K, Psatha P, et al.
(J Neurogastroenterol Motil 2012;18:169-173)
Since 1980, catheter-based 24-hour ambulatory pH monitor-
ing has been most commonly used to diagnose gastroesophageal 
reflux disease (GERD) objectively.
1 This system allows us the 
analysis of the quantified time of esophageal acid exposure, and 
the association between symptoms and reflux events. It has many 
advantages in elucidating the reason for failure of proton pump 
inhibitor (PPI) treatment in patients with reflux symptoms, doc-
umenting reflux before and after anti-reflux surgery, and assess-
ing the adequacy of acid control in patients with complicated 
GERD. Using dual sensor pH catheter, we can also analyze 
proximal acid reflux to the level of the pharynx. 
To measure the esophageal pH, the catheter should be 
passed trans-nasally, placed with manometric guidance, then tap-
ed to the patient’s nose, and removed after 24 hours. Absolutely, 
poor tolerance is the main disadvantage for catheter-based pH 
monitoring. It is uncomfortable, and induces social embarrass-
ment, and interrupts daily activity during the pH monitoring, 
which may affect the sensitivity of the test. One study reported 
that the patients during the test spent less time being active, were 
more likely to skip breakfast, and experienced dysphagia more of-
ten due to the catheter.
2 Moreover, a number of another dis-
advantages for catheter-based pH monitoring were noticed as 
follows. First is the variable sensitivity and specificity.
3-5 Upto 
23% of patients with erosive reflux disease showed false negative 
results. And 5% to 10% studies failed due to malpositioning. 
Another issue is the low reproducibility. One study showed that 
27% of patients showed discordant results in 2 separate day tests.
6 
Third, limited duration of examination, only 24 hours, leads to 
less reproducible and less sensitive results. 
Introduction of the catheter-free wireless pH monitoring us-
ing a radiotelemetry (433 MHz) pH sensing capsule that is at-
tached to the mucosa of the distal esophagus improved patient 
tolerability, ability to perform their daily activities and capability 
of performing extended recording periods of more than 48 hours 
(2-4 days).
7 In fact, one randomized cross over study comparing 
symptoms and daily activities between wireless pH and cathe-Joon Seong Lee
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Table. Results of Wireless pH Monitoring and Response to 
Proton Pump Inhibitor Trial
PPI response
Wireless pH monitoring
Total 
(N = 32) GERD 
(n = 20)
Non-GERD 
(n = 12)
Positive 18  2 20
Negative  2 10 12
Total 20 12 32
PPI, proton pump inhibitor; GERD, gastroesophageal reflux disease.
ter-based pH, revealed less adverse symptoms in wireless pH ex-
cept chest discomfort or pain, and less interference with daily ac-
tivities in wireless pH monitoring.
8
Increasing the recording duration may enhance the sensi-
tivity to detect reflux events. In retrospective analysis of 83 pa-
tients undergoing wireless pH monitoring upto 96 hours, 
Scarpulla noted that prolonged reflux studies increased the diag-
nostic yield of investigation.
9 In this study, diagnostic yield, sensi-
tivity and specificity were increased in 72 hour results and worst 
day results increased the sensitivity and diagnostic yield, but de-
creased the specificity.
Another advantage of wireless pH is availability to study both 
off and on PPI during 96 hour monitoring. Hirano elegantly 
demonstrated that although initial esophageal exposure was 
15.3% on day 1, after the administration of twice a day PPI, the 
acid exposure decreased to 1.3% on day 2, 1% on day 3 and 0.5% 
on day 4.
10
However, there are some disadvantages of wireless pH 
monitoring. Technically it cannot differentiate an acid swallow 
from acid reflux; there is the possibility to overestimate.
7 Also, the 
low sampling rate may miss short reflux episodes.
11,12 Additional-
ly in 10% of examinations, early detachment induced false low 
pH levels.
13 In contrast there may be lack of capsule detachment. 
Other disadvantages are chest pain or discomfort from the pH 
capsule placement, especially in patients with functional disor-
ders. Sometimes, severe pain may require endoscopic removal in 
under 2% of patients. Esophageal injury and rare life-threatening 
perforation were reported. And capsule placement may induce 
hypertensive esophageal contractions, which provoke chest pain 
or discomfort. Cost of endoscopy will be added to the cost of pH 
monitoring. Finally it cannot monitor the proximal esophagus 
and stomach. 
The studies comparing catheter-based to wireless capsu-
le-based monitoring for GERD have shown that the capsu-
le-based system may tend to underestimate reflux events.
11,12 The 
underestimation of wireless capsule pH may come from a lower 
sampling frequency (obtains data every 6 seconds) compared 
with catheter based pH system (every 4 seconds), and over-
estimation of catheter pH because the catheter entered the “acid 
pocket” during the transient lower esophageal sphincter relaxa-
tion with brief esophageal contraction and shortening.
14
Another recently developed system for reflux monitoring is 
impedance-pH testing. There are many theoretical potential 
advantages. It is the most sensitive technique for detecting all 
forms of reflux. It can detect all bolus movement, all types of re-
flux, and can also detect the nature of refluxate. Additionally it 
can detect esophageal volume clearance after reflux and proximal 
extent. Finally, it can increase yield of symptom association analy-
sis both in patients off and on PPI therapy.
15-17 The main draw-
backs of impedance pH monitoring are still catheter problems, 
and time consuming analysis using manual correction.
18 A recent 
study using on therapy impedance-pH compared with off ther-
apy wireless pH in refractory GERD, suggested abnormal im-
pedance-pH in patients on therapy predicted acid reflux of wire-
less pH in patients off therapy.
19
In this issue of Journal of Neurogastroenterology and Motility, 
Karamanolis et al
20 proved again that extended reflux studies im-
proved the detection of reflux and increased the sensitivity of 
testing.
20 They found an additional 12.1% gain in pathological 
esophageal acid exposure and an additional 12.5% gain in pos-
itive symptom index after 2 days in 32 patients with non-cardiac 
chest pain (NCCP). They also found that 90% (18) of patients 
with objective GERD by wireless pH experienced moderate or 
marked symptom improvement compared with only 16.7% (2) 
improvement in patients without GERD evidence. In patients 
with NCCP, the pooled sensitivity, specificity, and diagnostic 
odds ratio for the PPI test versus 24-hour pH monitoring and 
endoscopy were 80%, 74% and 13.83 (95% CI, 5.48-34.91), 
respectively.
21 Interestingly, in this study, the sensitivity, specific-
ity, positive predictive value, and negative predictive value for 
double dose PPI trial for 4 weeks versus 2-day wireless pH mon-
itoring were 90% (18/20), 83% (10/12), 90% (18/20) and 83% 
(10/12), respectively (Table).
21 This improvement of diagnostic 
yield for PPI trial compared with previous studies suggests that 
more correlated results to acid reflux could be obtained from 
wireless pH monitoring. Otherwise, PPI test is a very useful di-
agnostic method for patients with NCCP. Further studies for 
wireless pH in patients with extra-esophageal syndromes will be 
needed.
In conclusion, both catheter-based and wireless pH monitor-Is Wireless Capsule pH Monitoring Better Than Catheter Systems?
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ing are acceptable for distal esophageal monitoring. For re-
fractory GERD, on PPI impedance pH monitoring may be the 
single best strategy for evaluation of reflux symptoms. For a more 
tolerable prolonged study, wireless pH monitoring will be the 
best system known so far.
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